Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Robberecht

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Plos One|October 23, 2010
Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathyAngela S Laird, Annelies Van Hoecke, Louis De Muynck, et al.
Human Molecular Genetics|February 1, 2013
Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALSInes Taes, Mieke Timmers, Nicole Hersmus, et al.
Critical Care (London, England)|January 27, 2009
Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective studyGreet Hermans, Maarten Schrooten, Philip Van Damme, et al.
Human Molecular Genetics|April 29, 2017
Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivoSander Beel, Matthieu Moisse, Markus Damme, et al.
Molecular Neurodegeneration|October 18, 2018
Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 miceSander Beel, Sarah Herdewyn, Raheem Fazal, et al.
Human Brain Mapping|May 1, 2009
Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisitedCaroline A Sage, Wim Van Hecke, Ronald Peeters, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
Neurobiology of Aging|July 23, 2013
Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort studySarah Debray, Valérie Race, Veerle Crabbé, et al.
Human Molecular Genetics|December 10, 2019
Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapyAntina de Boer, Annet Storm, Maricel Gomez-Soler, et al.
Human Molecular Genetics|July 20, 2007
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafishRobin Lemmens, Annelies Van Hoecke, Nicole Hersmus, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Plos One|October 23, 2010
Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathyAngela S Laird, Annelies Van Hoecke, Louis De Muynck, et al.
Human Molecular Genetics|February 1, 2013
Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALSInes Taes, Mieke Timmers, Nicole Hersmus, et al.
Critical Care (London, England)|January 27, 2009
Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective studyGreet Hermans, Maarten Schrooten, Philip Van Damme, et al.
Human Molecular Genetics|April 29, 2017
Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivoSander Beel, Matthieu Moisse, Markus Damme, et al.
Molecular Neurodegeneration|October 18, 2018
Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 miceSander Beel, Sarah Herdewyn, Raheem Fazal, et al.
Human Brain Mapping|May 1, 2009
Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisitedCaroline A Sage, Wim Van Hecke, Ronald Peeters, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
Neurobiology of Aging|July 23, 2013
Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort studySarah Debray, Valérie Race, Veerle Crabbé, et al.
Human Molecular Genetics|December 10, 2019
Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapyAntina de Boer, Annet Storm, Maricel Gomez-Soler, et al.
Human Molecular Genetics|July 20, 2007
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafishRobin Lemmens, Annelies Van Hoecke, Nicole Hersmus, et al.
Pageof 19